A comparison of diagnostic criteria for neuroleptic malignant syndrome
- PMID: 1347292
A comparison of diagnostic criteria for neuroleptic malignant syndrome
Abstract
Background: A variety of diagnostic criteria for neuroleptic malignant syndrome (NMS) have been used in clinical studies of this disorder, but it is not known if different criteria consistently identify NMS. This study examines agreement between three frequently used sets of diagnostic criteria in a series of possible NMS episodes.
Method: All clinically suspected NMS episodes occurring at a large tertiary psychiatric facility during a 6-year period were evaluated by three different sets of diagnostic criteria. Agreement among these criteria was quantified statistically by means of the kappa and intraclass correlation coefficients.
Results: The NMS diagnostic criteria examined generally demonstrated only fair agreement with one another in the diagnosis of NMS. Agreement was best among these criteria when the "probable" category was employed. A complex interaction involving both definition and structure of individual diagnostic criteria and designation of criteria as major or minor appears to contribute to these findings.
Conclusion: The published diagnostic criteria used in this study do not consistently identify NMS episodes and demonstrate different thresholds for assigning this diagnosis. These differences are not due solely to different definitions of individual criteria (e.g., fever). Possible implications of these findings for clinical practice and research are discussed.
Similar articles
-
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Encephale. 2008. PMID: 19081460 Review. French.
-
Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.Ann Clin Psychiatry. 2007 Jan-Mar;19(1):9-16. doi: 10.1080/10401230601163477. Ann Clin Psychiatry. 2007. PMID: 17453656
-
Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.Pharmacotherapy. 2008 Apr;28(4):530-5. doi: 10.1592/phco.28.4.530. Pharmacotherapy. 2008. PMID: 18363536
-
Neuroleptic malignant syndrome: long-term follow-up of 20 cases.J Clin Psychiatry. 1991 May;52(5):208-12. J Clin Psychiatry. 1991. PMID: 1674508
-
[Studies of risk factors and preventive care for neuroleptic malignant syndrome].Nihon Shinkei Seishin Yakurigaku Zasshi. 2006 Nov;26(5-6):177-81. Nihon Shinkei Seishin Yakurigaku Zasshi. 2006. PMID: 17240842 Review. Japanese.
Cited by
-
Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register.Ther Adv Psychopharmacol. 2012 Apr;2(2):75-83. doi: 10.1177/2045125312438215. Ther Adv Psychopharmacol. 2012. PMID: 23983959 Free PMC article.
-
Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.CNS Drugs. 2009;23(6):477-92. doi: 10.2165/00023210-200923060-00003. CNS Drugs. 2009. PMID: 19480467 Review.
-
Neuroleptic malignant syndrome.J Neurol Neurosurg Psychiatry. 1995 Mar;58(3):271-3. doi: 10.1136/jnnp.58.3.271. J Neurol Neurosurg Psychiatry. 1995. PMID: 7897404 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources